Double-blind phase IV multicentre clinical trial to evaluate and compare specific and non specific effects of SCIT by use of an Environmental Challenge Chamber after treatment with Allergovit® grasses or Allergovit® birch in patients with grass and birch pollen allergy.
Phase of Trial: Phase IV
Latest Information Update: 07 Jun 2016
Price : $35 *
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Seasonal allergic rhinitis
- Focus Adverse reactions
- Sponsors Allergopharma
- 01 Jun 2016 Status changed from recruiting to completed.
- 26 Aug 2014 New trial record